There are lots of new illnesses and diseases plaguing us that were hitherto unknown. And many illnesses and diseases that we have known for millennia that have become more severe, and more common. I have regularly suggested that pharmaceutical drugs were one of the main reasons for this decline in health, and my ebook "DIE's - the Disease Inducing Effects of Pharmaceutical Drugs" provides the plentiful information that supports this supposition. Now, it would appear, the harm being caused by these drugs is affecting our sexual identity.
The website 'RxISK' is a free, independent drug safety website that helps weigh the benefits of pharmaceutical drugs against the potential dangers. It is an important website because it asks this important question.
"All drugs have side effects, but people often don’t link the effect they are experiencing to starting, stopping, or changing the dose of a drug. RxISK provides free access to information and tools to help you assess the connection between a drug and a side effect."
In October 2014, RxISK published an article, "Asexuality: a curious parallel". It noted the 'explosion' during the last two decades in the number of children being prescribed antidepressant, antipsychotic and stimulant drugs, and also the 'dramatic' increase in the number of children exposed to these drugs before they are born. It pointed out that SSRI antidepressants caused birth defects, and were implicated in causing autistic spectrum disorders. It stated that SSRIs had "a profound effect on brain chemistry after only a single dose", that patients, even after their first dose, "will be aware of some degree of reduced genital sensitivity within 30 minutes of taking the dose, and that "If an expectant mother is taking an SSRI, so is the unborn baby". It also added that all antidepressants transfer taken by mother's also transfer to the child through her breast milk.
Indeed, the article outlines a new condition, called Post-SSRI Sexual Dysfunction (PSSD), and referred to several articles published by RxISK, and referred to a published paper that looked at 120 cases of enduring sexual dysfunction. As RxISK stated,
"Given what we know about enduring sexual problems caused by SSRIs, it is reasonable to wonder how a prenatal or childhood exposure would affect a person’s long-term development and functioning. No studies have ever been done to investigate whether children exposed to psychotropic drugs either directly, or during pregnancy, grow up to have an unaffected sexuality."
Recently RxISK published two further articles on the issue, Asexuality, Transgender and SSRI's, published 31st October 2016, and Transgender, Asexuality and SSRIs, published 7th November 2016. They both raise the question of the link between SSRI antidepressant drugs and children with sexual identity issues. What is interesting about these articles is not so much the articles themselves, but the comments they have attracted from readers. This is testimony from individuals who have either experienced, or witnessed the sexual issues that have arisen from the pharmaceutical drugs implicated.
If the evidence of the link between SSRI drugs and sexual identity / transgender issues continues to increase, as it has done during recent years, a new issue will arise, not about the link between drugs and sexual identity, but focusing on denials by the pharmaceutical industry that any such a link exists, and the failure of the conventional medical establishment to do nothing about it.
The website 'RxISK' is a free, independent drug safety website that helps weigh the benefits of pharmaceutical drugs against the potential dangers. It is an important website because it asks this important question.
"All drugs have side effects, but people often don’t link the effect they are experiencing to starting, stopping, or changing the dose of a drug. RxISK provides free access to information and tools to help you assess the connection between a drug and a side effect."
In October 2014, RxISK published an article, "Asexuality: a curious parallel". It noted the 'explosion' during the last two decades in the number of children being prescribed antidepressant, antipsychotic and stimulant drugs, and also the 'dramatic' increase in the number of children exposed to these drugs before they are born. It pointed out that SSRI antidepressants caused birth defects, and were implicated in causing autistic spectrum disorders. It stated that SSRIs had "a profound effect on brain chemistry after only a single dose", that patients, even after their first dose, "will be aware of some degree of reduced genital sensitivity within 30 minutes of taking the dose, and that "If an expectant mother is taking an SSRI, so is the unborn baby". It also added that all antidepressants transfer taken by mother's also transfer to the child through her breast milk.
Indeed, the article outlines a new condition, called Post-SSRI Sexual Dysfunction (PSSD), and referred to several articles published by RxISK, and referred to a published paper that looked at 120 cases of enduring sexual dysfunction. As RxISK stated,
"Given what we know about enduring sexual problems caused by SSRIs, it is reasonable to wonder how a prenatal or childhood exposure would affect a person’s long-term development and functioning. No studies have ever been done to investigate whether children exposed to psychotropic drugs either directly, or during pregnancy, grow up to have an unaffected sexuality."
Recently RxISK published two further articles on the issue, Asexuality, Transgender and SSRI's, published 31st October 2016, and Transgender, Asexuality and SSRIs, published 7th November 2016. They both raise the question of the link between SSRI antidepressant drugs and children with sexual identity issues. What is interesting about these articles is not so much the articles themselves, but the comments they have attracted from readers. This is testimony from individuals who have either experienced, or witnessed the sexual issues that have arisen from the pharmaceutical drugs implicated.
If the evidence of the link between SSRI drugs and sexual identity / transgender issues continues to increase, as it has done during recent years, a new issue will arise, not about the link between drugs and sexual identity, but focusing on denials by the pharmaceutical industry that any such a link exists, and the failure of the conventional medical establishment to do nothing about it.
- We will be told that there has always been transgender children, the only difference being that now they are 'coming out'.
- The testimony of people affected by sexual identity issues will be dismissed as 'anecdotal' and 'unscientific'.
- The drugs industry will commission new 'scientific' studies that will discover there is no link between drugs and asexuality.
- And, of course, the media will refuse to discuss the issue.
The latter appears to have already begun. RxISK has noted that Wikipedia (a close friend of the pharmaceutical industry, so not a website that should be considered reliable on any health issue) has taken down its PSSD page. RxISK say that they restored it, but I have not been able to find it today (18 January 2017), so that too has probably been removed. It can, however, be found here, on the RxISK website.
Incidentally, the homeopathic community has attempted to publish a reasonable article on Wikipedia for some time, without success. The owner is, apparently, stolidly anti-homeopathy. So much for its claims to be an 'encyclopedia' of information and knowledge!
So, as the evidence of a link between pharmaceutical drugs and sexual identity issues is becoming compelling, the pharmaceutical industry is engaged in a massive cover-up, alongside its friends and allies. RxISK are doing an exceptional job with this issue, and others. They are, however, pushing up against very powerful and influential forces, who power and influence depends upon their continuing and ongoing ability to sell drugs, regardless of the harm they cause to patients, or, as it would seem, even the future of the human race!
POSTCRIPT
14th October 2019
Sexual identity and transgender issues continue to discussed, and the number of young people involved appears to be growing. Yet one report appears not to have hit the headlines. The Christian Post reported (26th September 2019) that drugs being used to halt puberty in gender-confused children have been linked to thousands of adult deaths.
POSTCRIPT
14th October 2019
Sexual identity and transgender issues continue to discussed, and the number of young people involved appears to be growing. Yet one report appears not to have hit the headlines. The Christian Post reported (26th September 2019) that drugs being used to halt puberty in gender-confused children have been linked to thousands of adult deaths.
"The Food & Drug Administration has recorded thousands of deaths associated with Lupron, a puberty-blocking drug that is routinely used to treat prostate cancer in men and endometriosis in women. Adverse complications related to its use include breast disorders, malignant neoplasms, and psychiatric and nervous disorders."
Lupron, and similar drugs, intentionally alters the hormone levels in the body. It is known that they contributed to blood clots, other cardiovascular complications, brittle bones and faulty joints.
"Between 2004 and June 30 of this year, the FDA documented 33,478 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 19,054 reactions were considered "serious," including 6,056 deaths."
So is this yet another case of pharmaceutical drugs CAUSING a problem, conventional medicine trying to TREAT it, and causing DISEASE AND DEATH in doing so?
